doi: 10.1186/1477-7525-9-83 Summary Keywords diabetes mellitus, glucagon-like peptides, hypoglycemic agents, adults, Colombia Citation Buenaventura-Collazos DC, Garca-Ramos AF, Balczar-Valencia CM, Aguilar-Londoo C, Coronel-Restrepo N, Monsalve-Arango CY, Cuesta-Castro DP and Ramrez-Rincn A (2024) Effectiveness and safety of once-weekly semaglutide: findings from the SEMACOL-REAL retrospective multicentric observational study in Colombia
Clinical trials, including a randomized clinical trial, proved it helps lower blood sugar levels and improve glycemic control for those with this condition
Jang HH et al
Starting doses (typically 0.25 mg weekly) are deliberately low to minimize nausea
Bring a concise packet: a current medication list with doses, recent symptom timestamps, a brief week-by-week food and activity notes, and any recent home blood glucose or BP readings, if relevant
Thats why we carefully consider the use of GLP-1 medications as part of an individualized treatment plan, alongside physical therapy, nutritional counseling, and other medical interventions